Macrophage-derived cytokine signaling

Macrophage-derived cytokine signaling refers to the complex network of communication mediated by proteins secreted by macrophages, such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6). These cytokines play a pivotal role in initiating and regulating the immune response, promoting inflammation, and coordinating the activities of other immune cells (Source: Nature Reviews Immunology, 2017). Dysregulation of this signaling pathway is a hallmark of various inflammatory and autoimmune disorders, including rheumatoid arthritis, Crohn's disease, and cytokine storm syndromes (Source: Frontiers in Immunology, 2020). In the tumor microenvironment, macrophage-derived signals can also promote cancer progression by stimulating angiogenesis and suppressing anti-tumor immunity (Source: PubMed, PMID: 31554302). Therapeutic strategies often focus on neutralizing specific cytokines or blocking their receptors and downstream signaling cascades, such as the JAK/STAT pathway, to mitigate tissue damage and chronic inflammation. While effective, modulating these pathways can lead to significant safety concerns, primarily related to impaired host defense against infections and potential malignancy (Source: StatPearls, 2023).

Other names

Macrophage cytokine productionMacrophage-mediated inflammationMonocyte-macrophage signaling pathway

Inhibition of pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6) or their receptors, and inhibition of downstream intracellular signaling molecules such as Janus kinases (JAKs).